Entrada Therapeutics, Inc. (TRDA)
5.72
-0.17
(-2.89%)
USD |
NASDAQ |
May 19, 14:55
Entrada Therapeutics Research and Development Expense (Quarterly) : 32.25M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 961.60M |
| Tyra Biosciences, Inc. | 33.33M |
| Biogen, Inc. | 471.10M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| XOMA Royalty Corp. | 0.049M |